HYDRODOXX 500 MG/G POWDER FOR USE IN DRINKING WATER FOR CHICKENS AND PIGS.
Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Charakteristika produktu
(SPC)
31-01-2015
Některé dokumenty pro tento produkt momentálně nejsou k dispozici, můžete poslat požadavek našemu zákaznickému servisu a my vás upozorníme, jakmile je dokážeme získat.
Poslat žádost.
Poslat žádost.
Aktivní složka:
DOXYCYCLINE HYCLATE
Dostupné s:
Huvepharma NV
ATC kód:
QJ01AA02
INN (Mezinárodní Name):
DOXYCYCLINE HYCLATE
Dávkování:
500 mg/g
Léková forma:
Powder for Oral Solution
Druh předpisu:
POM
Terapeutické skupiny:
Fowl - Chicken, Porcine
Terapeutické oblasti:
Doxycycline
Terapeutické indikace:
Antibacterial
Stav Autorizace:
Authorised
Datum autorizace:
2009-05-15
Charakteristika produktu
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
HydroDoxx 500 mg/g Powder for use in drinking water for chickens and pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One gram contains:
Active substance:
Doxycycline (as doxycycline hyclate)
500 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Powder for use in drinking water.
Yellow powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens (broilers)
Pigs (Fattening pigs)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Chickens (broilers) : Prevention and treatment of Chronic Respiratory Disease (CRD) caused by _Mycoplasma_
_gallisepticum _susceptible to doxycycline.
Fattening pigs: prevention and treatment of clinical respiratory infection caused by strains of _Pasteurella multocida_
susceptible to doxycycline.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not
possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the
target bacteria.
The presence of the clinical disease in the herd should be established before preventive treatment is started.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance, to other tetracyclines or to any excipient. Do not use in
animals with hepatic disorders.
Do not use in animals with renal disorders
See section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of
drinking water, animals should be treated parenterally.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 16/01/201
Přečtěte si celý dokument
